✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Kimia Biosciences Ltd.

KIMIABL

Market Cap
₹225 Cr.
P/E
23.38

Kimia Biosciences Ltd.

  • Kimia Biosciences
  • Coral Laboratories
  • Alpa Lab
FAQs on Kimia Biosciences Ltd. Shareprice

Kimia Biosciences has given lower returns compared to its competitors.
Kimia Biosciences has grown at ~16.02% over the last 5yrs while peers have grown at a median rate of 18.93%

Kimia Biosciences is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Kimia Biosciences is 23.38, while 3 year average PE is 15.59.
Also latest EV/EBITDA of Kimia Biosciences is 0 while 3yr average is 1050.

View FAQ's On Business
Growth Table
  • Kimia Biosciences Ltd.
  • Coral Laboratories
  • Alpa Lab
Balance Sheet
  • Kimia Biosciences Ltd.
  • Coral Laboratories
  • Alpa Lab
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Kimia Biosciences Ltd.
  • Coral Laboratories
  • Alpa Lab
Cash Flow
  • Kimia Biosciences Ltd.
  • Coral Laboratories
  • Alpa Lab
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Kimia Biosciences Ltd.
  • Coral Laboratories
  • Alpa Lab
Quarterly Results
  • Kimia Biosciences Ltd.
  • Coral Laboratories
  • Alpa Lab
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Kimia Biosciences Ltd. Financials

Balance sheet of Kimia Biosciences is moderately strong, But short term working capital might become an issue for this company.

The net debt of Kimia Biosciences is decreasing.
Latest net debt of Kimia Biosciences is ₹31.89 Crs as of Mar-25.
This is less than Mar-24 when it was ₹42.48 Crs.

Yes, profit is increasing.
The profit of Kimia Biosciences is ₹9.42 Crs for TTM, -₹5.31 Crs for Mar 2024 and -₹9.35 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Kimia Biosciences latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech